STOCK TITAN

[FWP] Morgan Stanley Free Writing Prospectus

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
FWP
Rhea-AI Filing Summary

Planet Labs PBC (NYSE: PL) filed a Form 8-K on 1 July 2025 under Item 7.01 (Reg FD). The company disclosed that it has entered into an unspecified agreement; details such as counterparties, scope, duration or financial terms were not provided in the filing.

The accompanying press release (Exhibit 99.1) states that the agreement does not alter Planet’s previously issued revenue, EBITDA and cash-flow guidance for the quarter ending 31 July 2025 or for fiscal year ending 31 January 2026, as last reaffirmed on 4 June 2025. Therefore, management views the arrangement as immaterial to its near-term financial outlook.

No other Items (e.g., 1.01 material definitive agreement, 2.02 results, 5.02 leadership changes) were triggered, suggesting the disclosure is strictly informational to comply with Regulation FD.

Key exhibits: 99.1 (press release) and 104 (iXBRL cover data). There are no financial statements, pro formas or updated risk factors included.

Planet Labs PBC (NYSE: PL) ha presentato un modulo 8-K il 1° luglio 2025 ai sensi dell'Articolo 7.01 (Reg FD). La società ha comunicato di aver stipulato un accordo non specificato; dettagli come le controparti, l'ambito, la durata o i termini finanziari non sono stati forniti nel documento.

Il comunicato stampa allegato (Esibizione 99.1) dichiara che l'accordo non modifica le precedenti previsioni di ricavi, EBITDA e flussi di cassa per il trimestre terminante il 31 luglio 2025 né per l'anno fiscale terminante il 31 gennaio 2026, come confermato l'ultima volta il 4 giugno 2025. Pertanto, la direzione considera l'accordo irrilevante per le prospettive finanziarie a breve termine.

Non sono stati attivati altri punti (ad esempio, 1.01 accordi definitivi rilevanti, 2.02 risultati, 5.02 cambiamenti di leadership), suggerendo che la comunicazione è esclusivamente informativa per conformarsi al Regolamento FD.

Principali allegati: 99.1 (comunicato stampa) e 104 (dati di copertura iXBRL). Non sono inclusi bilanci, pro forma o fattori di rischio aggiornati.

Planet Labs PBC (NYSE: PL) presentó un Formulario 8-K el 1 de julio de 2025 bajo el Punto 7.01 (Reg FD). La compañía reveló que ha celebrado un acuerdo no especificado; detalles como las contrapartes, el alcance, la duración o los términos financieros no fueron proporcionados en la presentación.

El comunicado de prensa adjunto (Exhibición 99.1) indica que el acuerdo no modifica las previsiones previamente emitidas de ingresos, EBITDA y flujo de caja para el trimestre que finaliza el 31 de julio de 2025 ni para el año fiscal que termina el 31 de enero de 2026, según lo reafirmado el 4 de junio de 2025. Por lo tanto, la gerencia considera que el acuerdo es irrelevante para sus perspectivas financieras a corto plazo.

No se activaron otros ítems (por ejemplo, 1.01 acuerdos definitivos materiales, 2.02 resultados, 5.02 cambios en el liderazgo), lo que sugiere que la divulgación es estrictamente informativa para cumplir con el Reglamento FD.

Exhibiciones clave: 99.1 (comunicado de prensa) y 104 (datos de portada iXBRL). No se incluyen estados financieros, pro forma ni factores de riesgo actualizados.

Planet Labs PBC (NYSE: PL)는 2025년 7월 1일 항목 7.01(Reg FD)에 따라 Form 8-K를 제출했습니다. 회사는 구체적으로 명시되지 않은 계약을 체결했음을 공개했으며, 상대방, 범위, 기간 또는 재무 조건과 같은 세부 사항은 제출서류에 제공되지 않았습니다.

첨부된 보도자료(전시물 99.1)에는 이 계약이 2025년 7월 31일 종료되는 분기 및 2026년 1월 31일 종료되는 회계연도에 대한 이전에 발표된 매출, EBITDA 및 현금 흐름 전망을 변경하지 않는다고 명시되어 있으며, 이는 2025년 6월 4일에 마지막으로 재확인된 내용입니다. 따라서 경영진은 이 계약이 단기 재무 전망에 중대한 영향을 미치지 않는다고 보고 있습니다.

다른 항목들(예: 1.01 중요 확정 계약, 2.02 실적, 5.02 리더십 변경)은 발동되지 않아, 이 공개가 규정 FD 준수를 위한 순수 정보 제공임을 시사합니다.

주요 전시물: 99.1(보도자료) 및 104(iXBRL 표지 데이터). 재무제표, 프로포마 또는 업데이트된 위험 요인은 포함되어 있지 않습니다.

Planet Labs PBC (NYSE : PL) a déposé un formulaire 8-K le 1er juillet 2025 en vertu de l'article 7.01 (Reg FD). La société a révélé avoir conclu un accord non spécifié ; des détails tels que les contreparties, la portée, la durée ou les conditions financières n'ont pas été fournis dans le dépôt.

Le communiqué de presse accompagnant (Exhibit 99.1) précise que l'accord n'altère pas les prévisions de revenus, d'EBITDA et de flux de trésorerie précédemment émises pour le trimestre se terminant le 31 juillet 2025 ni pour l'exercice se terminant le 31 janvier 2026, comme confirmé pour la dernière fois le 4 juin 2025. Par conséquent, la direction considère cet arrangement comme non significatif pour ses perspectives financières à court terme.

Aucun autre point (par exemple, 1.01 accord définitif matériel, 2.02 résultats, 5.02 changements de direction) n'a été déclenché, ce qui suggère que la divulgation est strictement informative afin de se conformer au règlement FD.

Pièces jointes clés : 99.1 (communiqué de presse) et 104 (données de couverture iXBRL). Aucun état financier, pro forma ou facteur de risque mis à jour n'est inclus.

Planet Labs PBC (NYSE: PL) reichte am 1. Juli 2025 ein Formular 8-K gemäß Punkt 7.01 (Reg FD) ein. Das Unternehmen gab bekannt, dass es eine nicht näher spezifizierte Vereinbarung getroffen hat; Details wie Vertragspartner, Umfang, Laufzeit oder finanzielle Bedingungen wurden in der Einreichung nicht angegeben.

Die beigefügte Pressemitteilung (Anlage 99.1) besagt, dass die Vereinbarung die zuvor veröffentlichten Umsatz-, EBITDA- und Cashflow-Prognosen für das Quartal zum 31. Juli 2025 sowie für das Geschäftsjahr zum 31. Januar 2026, zuletzt bestätigt am 4. Juni 2025, nicht verändert. Daher betrachtet das Management die Vereinbarung als unerheblich für die kurzfristige finanzielle Prognose.

Es wurden keine weiteren Punkte ausgelöst (z.B. 1.01 wesentliche endgültige Vereinbarung, 2.02 Ergebnisse, 5.02 Führungswechsel), was darauf hindeutet, dass die Offenlegung rein informativ zur Einhaltung der Regulation FD erfolgt.

Wichtige Anlagen: 99.1 (Pressemitteilung) und 104 (iXBRL-Cover-Daten). Es sind keine Finanzberichte, Pro-forma-Daten oder aktualisierte Risikofaktoren enthalten.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Neutral 8-K; new agreement announced, but guidance unchanged, implying limited near-term financial impact.

The filing supplies minimal quantitative or strategic context. Because management explicitly states FY26 and Q2 FY25 guidance remain intact, investors can infer the deal is neither large enough to uplift revenue nor dilutive to margins. Absence of Item 1.01 or 2.02 indicates the company believes the contract is not material under SEC thresholds. As such, valuation models and consensus estimates should remain unchanged. Impact: neutral.

Planet Labs PBC (NYSE: PL) ha presentato un modulo 8-K il 1° luglio 2025 ai sensi dell'Articolo 7.01 (Reg FD). La società ha comunicato di aver stipulato un accordo non specificato; dettagli come le controparti, l'ambito, la durata o i termini finanziari non sono stati forniti nel documento.

Il comunicato stampa allegato (Esibizione 99.1) dichiara che l'accordo non modifica le precedenti previsioni di ricavi, EBITDA e flussi di cassa per il trimestre terminante il 31 luglio 2025 né per l'anno fiscale terminante il 31 gennaio 2026, come confermato l'ultima volta il 4 giugno 2025. Pertanto, la direzione considera l'accordo irrilevante per le prospettive finanziarie a breve termine.

Non sono stati attivati altri punti (ad esempio, 1.01 accordi definitivi rilevanti, 2.02 risultati, 5.02 cambiamenti di leadership), suggerendo che la comunicazione è esclusivamente informativa per conformarsi al Regolamento FD.

Principali allegati: 99.1 (comunicato stampa) e 104 (dati di copertura iXBRL). Non sono inclusi bilanci, pro forma o fattori di rischio aggiornati.

Planet Labs PBC (NYSE: PL) presentó un Formulario 8-K el 1 de julio de 2025 bajo el Punto 7.01 (Reg FD). La compañía reveló que ha celebrado un acuerdo no especificado; detalles como las contrapartes, el alcance, la duración o los términos financieros no fueron proporcionados en la presentación.

El comunicado de prensa adjunto (Exhibición 99.1) indica que el acuerdo no modifica las previsiones previamente emitidas de ingresos, EBITDA y flujo de caja para el trimestre que finaliza el 31 de julio de 2025 ni para el año fiscal que termina el 31 de enero de 2026, según lo reafirmado el 4 de junio de 2025. Por lo tanto, la gerencia considera que el acuerdo es irrelevante para sus perspectivas financieras a corto plazo.

No se activaron otros ítems (por ejemplo, 1.01 acuerdos definitivos materiales, 2.02 resultados, 5.02 cambios en el liderazgo), lo que sugiere que la divulgación es estrictamente informativa para cumplir con el Reglamento FD.

Exhibiciones clave: 99.1 (comunicado de prensa) y 104 (datos de portada iXBRL). No se incluyen estados financieros, pro forma ni factores de riesgo actualizados.

Planet Labs PBC (NYSE: PL)는 2025년 7월 1일 항목 7.01(Reg FD)에 따라 Form 8-K를 제출했습니다. 회사는 구체적으로 명시되지 않은 계약을 체결했음을 공개했으며, 상대방, 범위, 기간 또는 재무 조건과 같은 세부 사항은 제출서류에 제공되지 않았습니다.

첨부된 보도자료(전시물 99.1)에는 이 계약이 2025년 7월 31일 종료되는 분기 및 2026년 1월 31일 종료되는 회계연도에 대한 이전에 발표된 매출, EBITDA 및 현금 흐름 전망을 변경하지 않는다고 명시되어 있으며, 이는 2025년 6월 4일에 마지막으로 재확인된 내용입니다. 따라서 경영진은 이 계약이 단기 재무 전망에 중대한 영향을 미치지 않는다고 보고 있습니다.

다른 항목들(예: 1.01 중요 확정 계약, 2.02 실적, 5.02 리더십 변경)은 발동되지 않아, 이 공개가 규정 FD 준수를 위한 순수 정보 제공임을 시사합니다.

주요 전시물: 99.1(보도자료) 및 104(iXBRL 표지 데이터). 재무제표, 프로포마 또는 업데이트된 위험 요인은 포함되어 있지 않습니다.

Planet Labs PBC (NYSE : PL) a déposé un formulaire 8-K le 1er juillet 2025 en vertu de l'article 7.01 (Reg FD). La société a révélé avoir conclu un accord non spécifié ; des détails tels que les contreparties, la portée, la durée ou les conditions financières n'ont pas été fournis dans le dépôt.

Le communiqué de presse accompagnant (Exhibit 99.1) précise que l'accord n'altère pas les prévisions de revenus, d'EBITDA et de flux de trésorerie précédemment émises pour le trimestre se terminant le 31 juillet 2025 ni pour l'exercice se terminant le 31 janvier 2026, comme confirmé pour la dernière fois le 4 juin 2025. Par conséquent, la direction considère cet arrangement comme non significatif pour ses perspectives financières à court terme.

Aucun autre point (par exemple, 1.01 accord définitif matériel, 2.02 résultats, 5.02 changements de direction) n'a été déclenché, ce qui suggère que la divulgation est strictement informative afin de se conformer au règlement FD.

Pièces jointes clés : 99.1 (communiqué de presse) et 104 (données de couverture iXBRL). Aucun état financier, pro forma ou facteur de risque mis à jour n'est inclus.

Planet Labs PBC (NYSE: PL) reichte am 1. Juli 2025 ein Formular 8-K gemäß Punkt 7.01 (Reg FD) ein. Das Unternehmen gab bekannt, dass es eine nicht näher spezifizierte Vereinbarung getroffen hat; Details wie Vertragspartner, Umfang, Laufzeit oder finanzielle Bedingungen wurden in der Einreichung nicht angegeben.

Die beigefügte Pressemitteilung (Anlage 99.1) besagt, dass die Vereinbarung die zuvor veröffentlichten Umsatz-, EBITDA- und Cashflow-Prognosen für das Quartal zum 31. Juli 2025 sowie für das Geschäftsjahr zum 31. Januar 2026, zuletzt bestätigt am 4. Juni 2025, nicht verändert. Daher betrachtet das Management die Vereinbarung als unerheblich für die kurzfristige finanzielle Prognose.

Es wurden keine weiteren Punkte ausgelöst (z.B. 1.01 wesentliche endgültige Vereinbarung, 2.02 Ergebnisse, 5.02 Führungswechsel), was darauf hindeutet, dass die Offenlegung rein informativ zur Einhaltung der Regulation FD erfolgt.

Wichtige Anlagen: 99.1 (Pressemitteilung) und 104 (iXBRL-Cover-Daten). Es sind keine Finanzberichte, Pro-forma-Daten oder aktualisierte Risikofaktoren enthalten.

Free Writing Prospectus to Preliminary Pricing Supplement No. 9,091

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 1, 2025; Filed pursuant to Rule 433

Morgan Stanley

Worst-of INDU, NDX and RTY Callable Contingent Income Securities due August 2, 2028

This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision.

Terms

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Underliers:

Dow Jones Industrial AverageSM (INDU), Nasdaq-100 Index® (NDX) and Russell 2000® Index (RTY)

Call feature:

Quarterly, based on the output of a risk neutral valuation model. See the accompanying preliminary pricing supplement.

Redemption dates:

Beginning after 6 months, quarterly

Contingent coupon:

7.00% to 8.00% per annum

Coupon payment dates:

Quarterly

Coupon barrier level:

70% of the initial level for each underlier

Downside threshold level:

70% of the initial level for each underlier

Pricing date:

July 28, 2025

Final observation date:

July 28, 2028

Maturity date:

August 2, 2028

CUSIP:

61778NCT6

Estimated value:

$935.10 per security, or within $45.00 of that estimate

Preliminary pricing supplement:

https://www.sec.gov/Archives/edgar/data/895421/000183988225035854/ms9091_424b2-19522.htm

1All payments are subject to our credit risk

 

Hypothetical Payment at Maturity1

(if the securities have not been redeemed)

% Change in Closing Level of the Worst Performing Underlier

Payment at Maturity per Security (excluding any contingent coupon payable at maturity)

+100.00%

$1,000.00

+80.00%

$1,000.00

+60.00%

$1,000.00

+40.00%

$1,000.00

+20.00%

$1,000.00

0.00%

$1,000.00

-20.00%

$1,000.00

-30.00%

$1,000.00

-31.00%

$690.00

-40.00%

$600.00

-60.00%

$400.00

-80.00%

$200.00

-100.00%

$0.00

 

 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.

Underlier(s)

For more information about the underlier(s), including historical performance information, see the accompanying preliminary pricing supplement.

Risk Considerations

The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.

Risks Relating to an Investment in the Securities

The securities do not guarantee the return of any principal.

The securities do not provide for the regular payment of interest.

Payment of the contingent coupon is based on the closing levels of the underliers on only the related observation date at the end of the related interest period.

Investors will not participate in any appreciation in the value of any underlier.

The securities are subject to early redemption risk.

The market price of the securities may be influenced by many unpredictable factors.

The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices.

The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.

The securities will not be listed on any securities exchange and secondary trading may be limited.

As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

The U.S. federal income tax consequences of an investment in the securities are uncertain.

Risks Relating to the Underlier(s)

Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

oYou are exposed to the price risk of each underlier.

oBecause the securities are linked to the performance of the worst performing underlier, you are exposed to a greater risk of not receiving a positive return on the securities and/or sustaining a significant loss on your investment than if the securities were linked to just one underlier.

oAdjustments to an underlying index could adversely affect the value of the securities.

The securities are subject to risks associated with small-capitalization companies.

Risks Relating to Conflicts of Interest

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

Tax Considerations

You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption “Additional Information About the Securities–United States federal income tax considerations” concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax adviser.

 

FAQ

What did Planet Labs (PL) announce in its 8-K dated July 1 2025?

The company entered into an agreement; no terms or counterparties were disclosed.

Does the new agreement affect Planet Labs’ FY26 guidance?

No. Management reiterated that previously issued guidance through 31 January 2026 remains unchanged.

Which exhibits accompany the 8-K filing?

Exhibit 99.1 is the press release about the agreement; Exhibit 104 contains cover-page iXBRL tags.

Was the agreement classified as a Material Definitive Agreement under Item 1.01?

No. The company furnished it under Item 7.01 (Reg FD), indicating it is considered non-material.

Are there any financial statements or pro forma data included?

No financial statements or pro formas were provided in this filing.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

231.25B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
NEW YORK